Publicaciones en colaboración con investigadores/as de University Health Network (23)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Guiding the global evolution of cytogenetic testing for hematologic malignancies

    Blood, Vol. 139, Núm. 15, pp. 2273-2284

2021

  1. Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19

    New England Journal of Medicine, Vol. 385, Núm. 9, pp. 790-802

2019

  1. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

    The Lancet Neurology, Vol. 18, Núm. 1, pp. 46-55

2018

  1. Encompassing new use cases - Level 3.0 of the HUPO-PSI format for molecular interactions

    BMC Bioinformatics, Vol. 19, Núm. 1

  2. Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 18, Núm. 10, pp. e401-e419

2015

  1. Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer

    Clinical Cancer Research, Vol. 21, Núm. 3, pp. 652-657

  2. Identification of six new susceptibility loci for invasive epithelial ovarian cancer

    Nature Genetics, Vol. 47, Núm. 2, pp. 164-171

2014

  1. Immune response to influenza A(H1N1)v in HIV-infected patients

    Journal of Infection in Developing Countries, Vol. 8, Núm. 1, pp. 101-109

2012

  1. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

2011

  1. Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenza

    BMC Infectious Diseases, Vol. 11

  2. Imbalanced pro- and anti-Th17 responses (IL-17/granulocyte colony-stimulating factor) predict fatal outcome in 2009 pandemic influenza

    Critical Care

  3. Inflammatory cytokine expression is associated with Chikungunya virus resolution and symptom severity

    PLoS Neglected Tropical Diseases, Vol. 5, Núm. 8

  4. The effects of agomelatine on sexual function in depressed patients and healthy volunteers

    Human Psychopharmacology, Vol. 26, Núm. 8, pp. 537-542

2010

  1. Host adaptive immunity deficiency in severe pandemic influenza

    Critical Care, Vol. 14, Núm. 5

  2. International network of cancer genome projects

    Nature, Vol. 464, Núm. 7291, pp. 993-998

2009

  1. Macrolides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains

    Journal of Infection in Developing Countries, Vol. 3, Núm. 3, pp. 159-161

  2. Nasopharyngeal aspirate cytokine levels 1 yr after severe respiratory syncytial virus infection

    Pediatric Allergy and Immunology, Vol. 20, Núm. 8, pp. 791-795

  3. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza

    Critical Care, Vol. 13, Núm. 6

2008

  1. Gene expression analysis of host innate immune responses during lethal H5N1 infection in ferrets

    Journal of Virology, Vol. 82, Núm. 22, pp. 11308-11317